UBS Group’s Artivion AORT Stock Holding History
Bought
Maintained
Sold
Other funds holding AORT
NAMI
VCM
PA
FAM
JIC
CCA
UBS Group's AORT Position: Q1 2026 in Review
UBS Group reduced its Artivion (AORT) stake by 8.1% in Q1 2026, selling an estimated $898K and leaving 256,922 shares worth $9.41M. The position accounts for ﹤0.01% of the portfolio, ranked #3428.
UBS Group first reported a position in AORT in Q4 2014 and has held it in 46 quarters since. The position peaked at $12.8M in Q4 2025. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.
- UBS Group held 256,922 shares of Artivion worth $9.41M as of Q1 2026.
- UBS Group sold 22,753 Artivion shares in Q1 2026, an estimated $898K.
- Artivion made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3428 holding.
- UBS Group first reported a position in Artivion in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Artivion position peaked at $12.8M in Q4 2025.
- 239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.